Study Details

Open

The Vanguard Study: Testing a New Way to Screen for Cancer

We're inviting you to join a study to help us understand more about cancer detection tests. Those who take part will be asked to give blood samples up to two times and complete questionnaires three times.

Age & Gender

45 years ~ 75 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)
Visits can be combined with regular clinical appointments

Location

North Carolina (Statewide)

What will be asked of you

When you join our study, you will give a blood sample and answer some questions at your first visit. One year later, we might ask you to give another blood sample and answer more questions. A year after that, we will ask you to answer a few questions again.

Incentives

Up to $100, Travel reimbursement available for those who test positive and will have a diagnostic work-up. Ask for more details on reimbursements.

In-person visits:
2

Phone or online visits:
3

Total length of participation:
24 Months

Looking for Healthy Volunteers

Requirements for healthy volunteers are different than for those with a specific condition. If you are interested in becoming a healthy volunteer for this study, use the below categories to determine if you are able to participate.

Able to participate:

Ages 45-75 years old
Agree to provide blood samples for possible MCD testing at enrollment and at 1 year.
Agree to allow collection of information from medical records for study-related purposes
Understand and are able to completed informed consent and participant questionnaires

Not eligible if:

Have a solid malignant tumor or blood cancer diagnosis within the last 5 years
Ongoing cancer diagnostic work-up
Ongoing participation in another study using investigational cancer screening tests or technology
Currently breastfeeding or pregnant, or plan to become pregnant in the next year

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Lineberger Clinical Trials Office
lccc_vanguardstudy@med.unc.edu
(919) 843-4863

Primary Visit Location

NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Dan Reuland
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Other Cancers)
Healthy Volunteer or General Population

IRB Number

25-1126

ClinicalTrials.gov

NCT06995898